Results

Total Results: 6,952 records

Showing results for "weeks".

  1. www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/patientsafety/2017qdr-patsafchartbook.pdf
    October 01, 2018 - National Healthcare Quality And Disparities Report Patient Safety Chartbook CHARTBOOK ON PATIENT SAFETY Updated October 2018 National Healthcare Quality and Disparities Report This document is in the public domain and may be used and reprinted without permission. Citation of the source is appreciated. Suggest…
  2. effectivehealthcare.ahrq.gov/sites/default/files/pdf/measuring-blood-pressure-future_research.pdf
    August 01, 2012 - reviewed pertinent publications through July 2011 and identified 47 comparative studies of at least 8 weeks … of the CER Results and conclusions from the CER are based on 47 comparative studies of at least 8 weeks
  3. digital.ahrq.gov/sites/default/files/docs/citation/cds-connect-environmental-scan.pdf
    December 01, 2017 - During the first 6 weeks of the CDS Connect effort, the MITRE team conducted an environmental scan of … (PDMP) and urine drug test (UDT) data to evaluate the risk of opioid misuse, reassess within 1- 4 weeks
  4. www.ahrq.gov/downloads/pub/evidence/pdf/bariatricrep/barirep.pdf
    November 01, 2008 - and lactation.56 Another case report documented iron and vitamin B12 deficiencies starting at six weeks … statistical difference in small for gestation age neonates (4 vs 2, p=NS), premature deliveries at <37 weeks … At the time of the adverse event, gestational age ranged from 25 to 36 weeks (median = 29.5 weeks). … Acute gastric ulcer perforation in a 35 weeks' nulliparous patient with gastric banding.
  5. effectivehealthcare.ahrq.gov/sites/default/files/related_files/pressure-ulcer-treatment_disposition-comments.pdf
    May 08, 2013 - pressure ulcers completely healed using the 281- subject dressing as compared to gauze at 8, 10 and 12 weeks … , with 51% of gauze-dressed subjects healed at 12 weeks compared to 61% of the highperforming hydrocolloid … Percents healed at 12 weeks using mainly the high-performing hydrocolloid dressing implementing a … Summary: The rate of closure was 50% at 4-weeks. … limitation of studies in our review was the duration of interventions and followup periods, typically a few weeks
  6. effectivehealthcare.ahrq.gov/sites/default/files/pdf/cancer-end-of-life-quality-meaures_research.pdf
    April 01, 2010 - the presence of an ICD9 diagnosis code 197.xx – 198.xx during a hospitalization or ED visit within 2 weeks … were used to define distant spread of the cancer if a claim with these codes was apparent within 2 weeks … determined during the 14 months prior to diagnosis date except metastasized cancers were defined in the two weeks
  7. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/screening-for-prediabetes-and-type-2-diabetes
    August 24, 2021 - worry, or self-reported health, but the results suggest possible short-term increases in anxiety (at 6 weeks … and no trial found a significant difference between groups over follow-up durations ranging from 8 weeks … anxiety, depression, worry, or self-reported health, but 1 reported short-term increases in anxiety (at 6 weeks
  8. www.uspreventiveservicestaskforce.org/home/getfilebytoken/bQNXFv9Q5uaAQvWH6B7VWV
    June 11, 2019 - have sex with men (mean age, 16-20 years; n = 272) found adherence to PrEP of approximately 50% at 12 weeks … and 22% to 34% at 48 weeks.49,50 An RCT (n = 179) of primarily (97%) US men who have sex with men found … adherence was higher with daily (48%) than with intermit- tent (31%) or event-driven (17%) PrEP during weeks
  9. www.ahrq.gov/sites/default/files/publications/files/universalicu.pdf
    September 01, 2013 - Several studies have shown 90 percent efficacy within 2 weeks of a 5-day regimen.24,25,26,27 It also … For example, a small number of baths could be observed in the weeks post-implementation. …  High rate of MRSA and MSSA eradication for first 2 weeks after 5-day application.
  10. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary-collaborative-modeling-of-us-breast-cancer-/breast-cancer-screening-january-2016
    January 11, 2016 - to undergoing screening (–0.006 for 1 week, or –1 hour), evaluating a positive screen (–0.105 for 5 weeks … Week Diagnostic phase (evaluation of positive screen) 0.895 0.105 (0.158, 0.210) 5 Weeks
  11. www.ahrq.gov/sites/default/files/2024-01/bailey-kilbridge-report.pdf
    January 01, 2024 - surveillance system for measuring the incidence of ADEs in the target pediatric populations within 4 weeks … One study found that approximately 11% of patients suffered adverse drug events during the 4 weeks following
  12. effectivehealthcare.ahrq.gov/sites/default/files/cognitive-decline-disposition-170707pdf.pdf
    March 24, 2017 - However, for context, we did comment on 2 studies of only 6 weeks duration that addressed IADLs. … Six months may be arbitrary but it seems much more reasonable than six weeks.
  13. effectivehealthcare.ahrq.gov/sites/default/files/related_files/cognitive-decline-disposition-170707pdf.pdf
    March 24, 2017 - However, for context, we did comment on 2 studies of only 6 weeks duration that addressed IADLs. … Six months may be arbitrary but it seems much more reasonable than six weeks.
  14. effectivehealthcare.ahrq.gov/sites/default/files/related_files/chronic-pain-opioid-treatment_disposition-comments.pdf
    September 29, 2014 - with some exceptions, there was little or no requirement to conduct pharma- sponsored trials beyond 12 weeks … specialist, I have been prescribed opioids and Lyrica and will have an infusion pump implanted in two weeks
  15. digital.ahrq.gov/sites/default/files/docs/page/EightSuccessStories_092810.pdf
    September 01, 2010 - Using Health IT: Eight Quality Improvement Stories Success stories Final_Layout 1 9/28/10 11:45 AM Page 2 Using Health IT: Eight Quality Improvement Stories Advancing Excellence in Health Care www.ahrq.gov Agency for Healthcare Research and Quality Health IT Success stories Final_Layout 1 9/28/10 11:4…
  16. www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patientsafetyculture/nursing-home/2016/nhsurv16-pt1.pdf
    January 01, 2016 - 2016 AHRQ Nursing Home Survey on Patient Safety Culture Part I PATIENT SAFETY NURSING HOME SURVEY ON PATIENT SAFETY CULTURE: 2016 User Comparative Database Report The authors of this report are responsible for its content. Statements in the report should not be construed as endorsement by the Agency for Health…
  17. effectivehealthcare.ahrq.gov/sites/default/files/fecal-incontinence_disposition-comments.pdf
    March 21, 2016 - Disposition of Comments for CER 165 Fecal Incontinence Comparative Effectiveness Review Disposition of Comments Report Research Review Title: Treatments for Fecal Incontinence Draft review available for public comment from June 1, 2015 to June 29, 2015. Research Review Citation: Forte ML, Andrade KE, Butler M, …
  18. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/72586/psn-pdf
    December 23, 2020 - Code Status vs. Care Status December 23, 2020 Krisman RK, Spero H. Code Status vs. Care Status. PSNet [internet]. 2020. https://psnet.ahrq.gov/web-mm/code-status-vs-care-status Disclosure of Relevant Financial Relationships: As a provider accredited by the Accreditation Council for Continuing Medical Education (AC…
  19. psnet.ahrq.gov/perspective/getting-patient-safety-personal-story
    August 01, 2006 - Getting Into Patient Safety: A Personal Story Jeffrey B. Cooper, PhD | August 1, 2006  Also Read a Conversation View more articles from the same authors. Citation Text: Cooper JB. Getting Into Patient Safety: A Personal Story. PSNet [internet]. Rockville (MD): A…
  20. digital.ahrq.gov/sites/default/files/docs/citation/r18hs026172-obrien-final-report-2022.pdf
    January 01, 2022 - Prevent Diabetes Mellitus (PreDM) Clinical Decision Support Intervention in Community Health Centers – Final Report TITLE: Prevent Diabetes Mellitus (PreDM) Clinical Decision Support Intervention in Community Health Centers PRINCIPAL INVESTIGATOR AND TEAM MEMBERS: Matthew J. O’Brien1,2; Maria C. Vargas1,2; Rona…